Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 4.968
Filtrar
1.
J Emerg Med ; 67(4): e379-e381, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-39183117

RESUMO

BACKGROUND: Hair thread tourniquet syndrome occurs when tissue is strangulated by a hair thread. It occurs most commonly in the digits of infants and young children, but can also occur in the genitalia. CASE REPORT: A 13-year-old postmenarchal girl with several days of severe vulvar pain and swelling presented to the emergency department. Diagnosis was unclear and she was referred to pediatric and adolescent gynecology. Pelvic examination under anesthesia revealed a hair thread tourniquet involving the bilateral labia minora. The hair tourniquet and portions of bilateral labia minora were excised. Why Should an Emergency Physician Be Aware of This? Genital hair thread tourniquet syndrome is uncommon but must be considered in patients with severe genital pain and swelling. Prompt diagnosis and treatment are important to prevent tissue necrosis and may be facilitated by means of a pelvic examination with sedation.


Assuntos
Diagnóstico Tardio , Cabelo , Humanos , Feminino , Adolescente , Diagnóstico Tardio/efeitos adversos , Vulva , Síndrome , Doenças da Vulva/diagnóstico , Doenças da Vulva/etiologia
2.
Expert Opin Pharmacother ; 25(11): 1541-1554, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-39129457

RESUMO

INTRODUCTION: The demand for effective and safe treatments of genitourinary syndrome (GSM) in post-menopausal women (PMW) is growing. Published data on the efficacy and safety of ospemifene (OSP) prompt an updated literature review to enlighten possible improvements in the GSM treatment. AREA COVERED: We searched articles published in English from 2010 to 2023 through Medline (PubMed) and Embase databases with Boolean terms: OSP, PMW, GSM, endometrium, breast cancer, cardiometabolic syndrome, bone metabolism, adherence to treatment, and patient satisfaction. We selected randomized controlled trials (RCTs) and observational and cross-sectional studies and completed the search manually. EXPERT OPINION: Of the 157 retrieved records, 25 primary studies met the inclusion criteria (15 regarding efficacy and safety, two for additional effects, and four for adherence and satisfaction with the OSP treatment). Seven RCTs involved nearly 5,000 patients, 10 out of 18 prospective observational studies 563, and six retrospective analyses 356,439. Evidence of OSP treatment in PMW with GSM relies on RCTs and remarkable real-world data. The 25 primary studies showcased the high clinical response to symptoms, the favorable safety profile of OSP with very few adverse events, a neutral impact on the endometrium, breast, bone, and thrombosis, and the possible improvement of cardiovascular risk factors.


Assuntos
Atrofia , Pós-Menopausa , Tamoxifeno , Vagina , Vulva , Humanos , Feminino , Atrofia/tratamento farmacológico , Tamoxifeno/uso terapêutico , Tamoxifeno/análogos & derivados , Tamoxifeno/efeitos adversos , Vagina/patologia , Vagina/efeitos dos fármacos , Vulva/patologia , Vulva/efeitos dos fármacos , Ensaios Clínicos Controlados Aleatórios como Assunto , Moduladores Seletivos de Receptor Estrogênico/uso terapêutico , Moduladores Seletivos de Receptor Estrogênico/efeitos adversos , Doenças Urogenitais Femininas/tratamento farmacológico
3.
Eur J Obstet Gynecol Reprod Biol ; 301: 240-245, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-39167877

RESUMO

INTRODUCTION: Vaginal delivery has several benefits for the parturient; however, during labor, some injuries, such as lacerations and/or episiotomy, can occur. Perineal pain may occur in the puerperium and can be aggravated in cases of perineal injury during childbirth, potentially impacting the physical and emotional aspects of the parturient. For this reason, it is necessary to use techniques that can relieve pain and edema in the immediate postpartum period, directly influencing recovery. OBJECTIVE: To compare the reduction of pain and improvement in healing using two techniques, namely photobiomodulation and cryotherapy, performed in the immediate postpartum period of up to 12 h, in parturients who suffered grade I and II lacerations and/or episiotomy. METHODS: Data collection was carried out through an evaluation questionnaire. Photobiomodulation was applied using the red and infrared laser from the DMC brand. The EVA and McGill scales were used for pain assessment, and the REEDA scale was used for the evaluation of edema and healing. RESULTS: The techniques were evaluated and applied to 56 patients, with 28 in each group (cryotherapy and LBI). Patients who received photobiomodulation showed superior improvement compared to cryotherapy. In the immediate postpartum period, there was a greater reduction in pain in favor of photobiomodulation (p = 0.008); and after 24 h, the difference was even more significant (p < 0.001).


Assuntos
Crioterapia , Edema , Episiotomia , Lacerações , Terapia com Luz de Baixa Intensidade , Períneo , Período Pós-Parto , Humanos , Feminino , Crioterapia/métodos , Períneo/lesões , Episiotomia/efeitos adversos , Adulto , Edema/prevenção & controle , Edema/terapia , Edema/etiologia , Gravidez , Lacerações/terapia , Terapia com Luz de Baixa Intensidade/métodos , Doenças da Vulva/terapia , Vulva , Adulto Jovem , Medição da Dor , Parto Obstétrico/efeitos adversos
4.
Menopause ; 31(9): 801-808, 2024 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-38954491

RESUMO

OBJECTIVE: To compare patient satisfaction rate in postmenopausal women who chose dynamic quadripolar radiofrequency or topical estrogens as their preferred treatment for genitourinary syndrome of menopause. METHODS: Patients were divided into two groups according to their preference: one was treated with estrogen therapy (ET) and the other with dynamic quadripolar radiofrequency treatment (RF). All patients included fulfilled a series of validated questionnaires, at baseline and at the 6-mo follow-up, in order to evaluate the discomfort degree associated with the presence of vulvovaginal atrophy and the impact of the reported symptoms on QoL and sexuality. RESULTS: After propensity score matching, the proportion of women considering themselves satisfied with their genital health conditions was extremely small at study entry (5.2% of the RF group and 6.9% of the ET group), while at a 6-mo follow-up, it increased to 46.7% and 46.6%, respectively. No statistically significant between-group differences were found regarding mean numerical rating scale scores for dryness and dyspareunia at follow-up (5.6 ± 2.6 vs 5.3 ± 2.3, P = 0.5; and 2.9 ± 2.5 vs 3.0 ± 2.7, P = 0.46). At 6-mo follow-up, we observed no statistically significant differences between the two groups regarding the other items evaluated. RF treatment was overall well tolerated. CONCLUSION: The use of quadripolar radiofrequency devices seems effective, but it is not associated with better clinical outcomes compared with topical hormone treatment, which is a substantially cheaper and more convenient treatment for genitourinary syndrome of menopause. Therefore, we suggest limiting the use of dynamic quadripolar radiofrequency selectively when topical estrogens are not effective, not tolerated, or contraindicated.


Assuntos
Atrofia , Estrogênios , Preferência do Paciente , Pós-Menopausa , Vagina , Vulva , Humanos , Feminino , Pessoa de Meia-Idade , Vulva/patologia , Vagina/patologia , Estrogênios/administração & dosagem , Estrogênios/uso terapêutico , Dispareunia/tratamento farmacológico , Dispareunia/terapia , Inquéritos e Questionários , Terapia de Reposição de Estrogênios/métodos , Satisfação do Paciente , Qualidade de Vida , Idoso , Terapia por Radiofrequência/métodos , Resultado do Tratamento , Doenças Vaginais/tratamento farmacológico , Doenças Vaginais/terapia
5.
BMJ Case Rep ; 17(7)2024 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-38955387

RESUMO

A woman in her 70s was seen in the gynaecology outpatient clinic with a swelling on the right side of the vulva. Surgical excision of the lesion revealed unexpectedly an extensive ductal carcinoma in situ with a focus of a grade 2 invasive ductal carcinoma arising in extramammary breast tissue of the vulva. Postoperative staging studies showed normal breasts, with no evidence of disease elsewhere. The patient underwent a wider excision of the right vulva and sentinel node biopsy of the right inguinal region, which revealed no further disease. The patient is currently taking adjuvant hormonal therapy and has remained disease free at 2-year follow-up. This case underscores the importance of considering rare presentations of vulvar malignancies and the necessity for a multidisciplinary approach in managing such cases.


Assuntos
Neoplasias da Mama , Neoplasias Vulvares , Humanos , Feminino , Neoplasias Vulvares/patologia , Neoplasias Vulvares/cirurgia , Neoplasias Vulvares/diagnóstico , Idoso , Neoplasias da Mama/patologia , Neoplasias da Mama/cirurgia , Biópsia de Linfonodo Sentinela , Vulva/patologia , Vulva/cirurgia , Carcinoma Intraductal não Infiltrante/patologia , Carcinoma Intraductal não Infiltrante/diagnóstico , Carcinoma Intraductal não Infiltrante/cirurgia
6.
Dis Model Mech ; 17(8)2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-38946472

RESUMO

Ras genes are important oncogenes that are frequently mutated in cancer. Human oncogenic variants exhibit functional distinctions in terms of their representation in different cancer types, impact on cellular targets and sensitivity to pharmacological treatments. However, how these distinct variants influence and respond to the cellular networks in which they are embedded is poorly understood. To identify novel participants in the complex interplay between Ras genotype and cell interaction networks in vivo, we have developed and tested an experimental framework using a simple vulva-development assay in the nematode C. elegans. Using this system, we evaluated a set of Ras oncogenic substitution changes at G12, G13 and Q61. We found that these variants fall into distinct groups based on phenotypic differences, sensitivity to gene dosage and inhibition of the downstream kinase MEK and their response to genetic modulators that influence Ras activity in a non-autonomous manner. Together, our results demonstrated that oncogenic C. elegans Ras variants exhibit clear distinctions in how they interface with the vulva-development network and showed that extracellular modulators yield variant-restricted effects in vivo.


Assuntos
Caenorhabditis elegans , Vulva , Proteínas ras , Caenorhabditis elegans/genética , Animais , Vulva/patologia , Vulva/metabolismo , Proteínas ras/metabolismo , Proteínas ras/genética , Proteínas de Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/genética , Feminino , Fenótipo , Mutação/genética , Oncogenes/genética , Humanos
7.
Womens Health (Lond) ; 20: 17455057241266532, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39066559

RESUMO

Lipomas are common benign adipose tissue tumors but are infrequently found in the labia majora, especially at a large size. We report a case of a giant lipoma of the labia majora in a 37-year-old woman diagnosed by imaging methods and successfully treated by surgery. This case highlights the importance of considering lipoma in the differential diagnosis of labial masses and underscores the role of imaging in diagnosis. They need to be differentiated from liposarcoma or omental herniation into Nuck's canal. It also demonstrates the effectiveness of surgical management for large lipomas in sensitive areas, with attention to both medical and aesthetic outcomes.


Assuntos
Lipoma , Neoplasias Vulvares , Humanos , Feminino , Adulto , Lipoma/cirurgia , Lipoma/patologia , Lipoma/diagnóstico por imagem , Lipoma/diagnóstico , Neoplasias Vulvares/cirurgia , Neoplasias Vulvares/patologia , Neoplasias Vulvares/diagnóstico , Diagnóstico Diferencial , Vulva/patologia , Vulva/cirurgia , Imageamento por Ressonância Magnética
8.
Medicina (Kaunas) ; 60(7)2024 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-39064488

RESUMO

Background and Objectives: Postmenopausal vaginal discomfort is often attributed to vulvovaginal atrophy (VVA). Women with VVA experience symptoms such as vaginal dryness, itching, burning, irritation, and dyspareunia. Materials and Methods: This pilot study was conducted to assess the effects of a micro-ablative fractional CO2 laser on the clinical symptoms of VVA, as well as concordant sexual function. The severity of VVA symptoms was evaluated by a visual analogue scale (VAS), while the condition of the vaginal mucosa was evaluated using the Vaginal Health Index Score (VHSI). Sexual function was evaluated using the Female Sexual Function Index (FSFI) Questionnaire. Results: Our cohort included 84 sexually active postmenopausal women with bothersome VVA, leading to sexual health complaints. The mean age of the participants in our study was 55.2 ± 5.4 years, with an average postmenopausal period of 6 ± 4.8 years. The age of our patients and the length of their postmenopausal period exhibited a significant negative correlation with VHSI scores, while a longer postmenopausal period was associated with increased severity of vaginal dryness and dyspareunia. Baseline VHSI values showed that 65% of patients had atrophic vaginitis with pronounced VVA symptoms (70.2% experienced vaginal itching, 73.8% reported vaginal burning, 95.3% had vaginal dryness, and 86.1% suffered from dyspareunia). Lower VHSI values significantly correlated with lower FSFI scores, while more severe VVA symptoms scores correlated with lower FSFI scores. VVA symptoms were significantly less severe after treatment. VHIS regained high non-atrophic values in 98.8% of patients post-treatment (p < 0.001). FSFI total and domain scores were significantly higher after treatment (p < 0.001). Conclusions: Our study revealed that fractional CO2 laser is a useful treatment option to alleviate VVA symptoms and improve vaginal health and sexual functioning in postmenopausal women.


Assuntos
Atrofia , Lasers de Gás , Vagina , Vulva , Humanos , Feminino , Pessoa de Meia-Idade , Projetos Piloto , Lasers de Gás/uso terapêutico , Vagina/cirurgia , Vagina/patologia , Vulva/patologia , Vulva/cirurgia , Pós-Menopausa , Doenças Vaginais/cirurgia , Dispareunia/etiologia , Inquéritos e Questionários , Resultado do Tratamento , Idoso , Doenças da Vulva/cirurgia
9.
Nutrients ; 16(14)2024 Jul 22.
Artigo em Inglês | MEDLINE | ID: mdl-39064821

RESUMO

BACKGROUND: Postmenopausal dyspareunia and vulvar pain are common complaints, affecting about 60% of women within a few years after hormone levels begin to decline (such as estrogen and androgen). Atrophic changes mainly located in the vulvar vestibule and vulnerability to vulvovaginal infections in postmenopause could be predisposing factors to the development of vulvar burning/pain and introital dyspareunia (vestibulodynia secondary to atrophy). Tibolone is the most effective and safe alternative for treating menopausal symptoms. The role of Lactobacilli and lactoferrin shows its effectiveness in the treatment of vaginal microbiota dysbiosis. The aim of the present study was to assess the efficacy of the combination of tibolone and an oral-specific Lactobacilli mixture in combination with bovine lactoferrin as synergistic therapy for the treatment of vestibulodynia related to atrophy. METHODS: In this study, we included 35 postmenopausal women with at least 1 year of amenorrhea, affected by vulvar burning/pain and introital dyspareunia. All participants received treatment with open-label, oral Tibolone 2.5 mg and Lactobacilli mixture (5 × 109 CFU per capsule) in combination with bovine lactoferrin (Respecta®). Each product was taken once daily for 90 days. RESULTS: After 90 d of therapy with TIB+ Respecta®, in 30 women that completed the treatment, there was a statistically significant decrease from the baseline in the mean of the Visual Analog Scale for vulvar burning/pain and a reduction in scores in the pain evaluation test. CONCLUSIONS: This study provides evidence that the combination of TIB+ Respecta® was effective in reducing symptoms related to vestibular pain and hypersensitivity in a postmenopausal setting.


Assuntos
Lactobacillus , Lactoferrina , Norpregnenos , Pós-Menopausa , Feminino , Humanos , Lactoferrina/administração & dosagem , Pessoa de Meia-Idade , Norpregnenos/administração & dosagem , Vulvodinia/tratamento farmacológico , Vulvodinia/terapia , Probióticos/administração & dosagem , Resultado do Tratamento , Dispareunia/tratamento farmacológico , Dispareunia/terapia , Vulva/microbiologia
10.
J Plast Reconstr Aesthet Surg ; 95: 331-339, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38955111

RESUMO

INTRODUCTION: Lichen sclerosus et atrophicus is an inflammatory, scarring dermatosis of the female anogenital area and may lead to pain and sexual dysfunction. In select cases which are refractory to conservative therapy, surgery may provide significant symptom improvement. The objective of this study was to expand the range of surgical treatment options for these patients by presenting the operative outcomes of a specialised reconstructive method using the anterior obturator artery perforator (aOAP) flap. METHODS: A retrospective cohort study was conducted on sexual outcomes following the excision of affected vulvovestibular tissue by skinning vulvectomy and subsequent single-stage reconstruction using the aOAP flap. Additional procedures, such as the Omega-Domed (OD) flap, scar surgery and clitoral re-exposure, were performed when indicated. RESULTS: Between 2014 and 2022, a total of 61 patients were surgically treated and retrospectively included in this study. Vulvectomy and subsequent reconstruction with bilateral aOAP flaps were performed in 53 (87%) cases. There was a significant reduction in the prevalence of dyspareunia and inability to have sexual intercourse at the 1-year follow-up compared to baseline (p < 0.001). There were several minor, reversible complications that required secondary intervention. CONCLUSIONS: The outcomes of this study indicate a substantial improvement in sexual function, evidenced by a significant reduction in dyspareunia and an increased ability to engage in sexual intercourse. Altered tissue quality in patients with lichen sclerosus et atrophicus and long-term cortisone application may predispose this patient population to a higher risk of minor post-operative complications. CLINICAL TRIAL REGISTRATION NUMBER: DRKS00033261.


Assuntos
Líquen Escleroso e Atrófico , Retalho Perfurante , Adulto , Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Líquen Escleroso e Atrófico/complicações , Líquen Escleroso e Atrófico/cirurgia , Retalho Perfurante/irrigação sanguínea , Procedimentos de Cirurgia Plástica/métodos , Estudos Retrospectivos , Disfunções Sexuais Fisiológicas/etiologia , Resultado do Tratamento , Vulva/cirurgia , Vulvectomia/métodos
11.
JAMA Dermatol ; 160(8): 891-892, 2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-38865150

RESUMO

A woman in her 30s presented with mildly itchy skin nodules in the vulvar region for 1 year, which occurred during pregnancy and increased gradually in size and number without any treatments. What is your diagnosis?


Assuntos
Doenças da Vulva , Humanos , Feminino , Doenças da Vulva/diagnóstico , Doenças da Vulva/patologia , Neoplasias Vulvares/patologia , Neoplasias Vulvares/diagnóstico , Biópsia , Vulva/patologia
12.
BMC Womens Health ; 24(1): 370, 2024 Jun 26.
Artigo em Inglês | MEDLINE | ID: mdl-38918726

RESUMO

OBJECTIVE: Underdiagnosis of female genital tuberculosis (FGTB) often leads to infertility. In this study, we aimed to determine the site and histopathologic patterns of FGTB and its correlation with clinical presentation and acid-fast bacilli (AFB) status. METHODS: A retrospective cross-sectional study was conducted on 122 patients with a histopathological diagnosis of FGTB at the Department of Pathology, College of Health Sciences (CHS), Tikur Anbessa Specialized Hospital (TASH), Addis Ababa University (AAU), from January 1, 2013, to August 30, 2022. RESULTS: Female genital tuberculosis was found in 0.94% of the gynecology specimens examined. The most common presentations were menstrual disturbance, abdominopelvic pain, and infertility. Among patients with FGTB, 4.6% exhibited misleading clinical and radiologic findings, leading to suspicion of malignancy and subsequent aggressive surgical management. The endometrium was the most frequently affected organ, followed by the fallopian tube, ovary, cervix, and vulva. In the majority of tuberculous endometritis cases (53.3%), histopathology revealed early-stage granulomas. Acid-fast bacilli were found in a significant proportion (42.6%) of FGTB tissues with TB histopathology. The ovary had the highest rate of AFB detection, followed by the fallopian tube, endometrium, and cervix. CONCLUSION: Female genital tuberculosis should be considered in reproductive-age women presenting with menstrual irregularities, abdominopelvic pain, infertility, or an abdominopelvic mass. The endometrium is commonly affected, displaying early granulomas with low AFB positivity.


Assuntos
Tuberculose dos Genitais Femininos , Humanos , Feminino , Tuberculose dos Genitais Femininos/patologia , Tuberculose dos Genitais Femininos/diagnóstico , Tuberculose dos Genitais Femininos/complicações , Estudos Transversais , Estudos Retrospectivos , Adulto , Etiópia/epidemiologia , Adulto Jovem , Pessoa de Meia-Idade , Distúrbios Menstruais/patologia , Infertilidade Feminina/etiologia , Endométrio/patologia , Endométrio/microbiologia , Adolescente , Colo do Útero/patologia , Colo do Útero/microbiologia , Dor Pélvica/etiologia , Tubas Uterinas/patologia , Tubas Uterinas/microbiologia , Ovário/patologia , Dor Abdominal/etiologia , Vulva/patologia , Vulva/microbiologia , Endometrite/patologia , Endometrite/microbiologia , Endometrite/diagnóstico
13.
Pathology ; 56(6): 854-864, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-38906758

RESUMO

Vulvar and vaginal melanomas (VVMs) are rare and aggressive malignancies with limited prognostic models available and there is no standard reporting protocol. VVMs were selected from six tertiary Canadian hospitals from 2000-2021, resected from patients aged ≥18 years, with 6 months or longer follow-up data, and confirmation of melanocytic differentiation by at least two immunohistochemical markers. Cases were reviewed by pathologists to identify histological biomarkers. Survival outcomes were tested with Kaplan-Meier log-rank, univariate Cox, and multivariate Cox regression. There were 79 VVMs with median follow-up at 26 months. Univariate analysis revealed that tumour necrosis, tumour ulceration, positive lymph nodes, and metastasis at diagnosis were significantly associated with disease-specific mortality, progression, and metastasis. Multivariate analysis identified tumour necrosis as an independent prognostic factor for disease-specific mortality (HR 4.803, 95% CI 1.954-11.803, p<0.001), progression (HR 2.676, 95% CI 1.403-5.102, p=0.003), and time-to-metastasis for non-metastatic patients at diagnosis (HR 3.761, 95%CI 1.678-8.431, p=0.001). Kaplan-Meier survival analyses demonstrated that tumour necrosis was a poor prognostic factor for disease-specific, progression-free, and metastasis-free survival (p<0.001 for all comparisons). Vaginal melanomas displayed decreased survival compared to vulvar or clitoral melanomas. This study identifies tumour necrosis as an independent prognostic factor for VVMs. Vaginal melanomas specifically showed worse survival outcomes compared to vulvar or clitoral melanomas, consistent with previously reported findings in the literature, emphasising the importance of differentiating between these primary tumour epicentres for prognostication and treatment planning in the care of genital melanoma patients.


Assuntos
Melanoma , Necrose , Neoplasias Vaginais , Neoplasias Vulvares , Humanos , Feminino , Melanoma/patologia , Melanoma/mortalidade , Melanoma/diagnóstico , Neoplasias Vulvares/patologia , Neoplasias Vulvares/mortalidade , Neoplasias Vaginais/patologia , Neoplasias Vaginais/mortalidade , Neoplasias Vaginais/diagnóstico , Prognóstico , Pessoa de Meia-Idade , Idoso , Adulto , Idoso de 80 Anos ou mais , Estimativa de Kaplan-Meier , Vulva/patologia
14.
Arch Gynecol Obstet ; 310(2): 631-641, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38898186

RESUMO

PURPOSE: Tumors affecting the female genital tract and their treatments have the potential to induce adverse modifications in vaginal health and impact personal aspects of patient's lives. Vulvovaginal atrophy is one of the morphological changes observed in individuals with a history of gynecological cancer, influenced both by the biological environment of tumors and the main therapeutic modalities employed. Therefore, the purpose of this study was to identify approaches to treat vulvovaginal atrophy while assessing the impact on the emotional and sexual health of women diagnosed with gynecological cancers. METHODS: To achieve this goal, a systematic review was conducted following the methodological guidelines outlined by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The databases used for literature research were PubMed and Web of Science. RESULTS: Initially, 886 articles were obtained. After eliminating duplicates and applying inclusion/exclusion criteria, seven articles were selected for analysis. The period of highest publication activity spanned from 2017 to 2020, with the majority conducted in Italy. Five treatment modalities were identified and categorized as vaginal suppository, oral medication, surgical procedure, CO2 laser therapy, and vaginal dilator. Twenty-four outcomes related to vaginal health and 30 outcomes related to overall, sexual, and emotional quality of life were analyzed. CONCLUSION: In general, all interventions demonstrated the ability to improve vaginal health or, at the very least, the sexual health of patients. Thus, despite limitations, all treatments have the potential to address vulvovaginal atrophy in patients with a history of gynecological cancer.


Assuntos
Atrofia , Neoplasias dos Genitais Femininos , Qualidade de Vida , Vagina , Vulva , Humanos , Feminino , Neoplasias dos Genitais Femininos/terapia , Neoplasias dos Genitais Femininos/psicologia , Neoplasias dos Genitais Femininos/patologia , Vagina/patologia , Vulva/patologia , Doenças Vaginais/terapia , Doenças Vaginais/patologia , Lasers de Gás/uso terapêutico , Supositórios , Administração Intravaginal
15.
Aesthetic Plast Surg ; 48(16): 3180-3186, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38727844

RESUMO

BACKGROUND: To compare the fat transfer combined with plasma energy and only fat transfer methods for genital rejuvenation and to investigate the efficacy enhancing properties of plasma energy. METHODS: Forty-six patients were equally divided into two groups according to the surgical method as the group A (n = 23) and the group B (n = 23). The patients in the group A received only fat transfer, while the patients in the group B received fat transfer combined with plasma energy. Both groups were scheduled for postoperative follow-up at 1, 3, 6, and 12 months. The lifting effect on the labia majora after the procedure was evaluated with photographs and patient satisfaction questionnaires including the female genital self-image scale (FGSIS). RESULTS: The mean age of all participants was 32.8 ± 5.1 years, and the mean body mass index (BMI) was 24.7 ± 3.4 kg/m2. The mean preoperative FGSIS scores were similar between the groups (p = 0.542). The mean total FGSIS score was 18.8 ± 1.4 in the group A and 18.3 ± 1.5 in the group B in the preoperative period. However, the mean FGSIS scores at 1, 3, and 6 months were significantly higher in the group B than the group A (p = 0.032, p = 0.012, and p = 0.009, respectively). At 6 months of follow-up, the mean total FGSIS score was 20.7 ± 1.4 in the group A and 22.3 ± 1.5 in the group B, indicating a statistically significant difference (p = 0.028). CONCLUSION: This novel technique is a more minimally invasive technique compared to other energy modalities with lower lateral and vertical energy dissipation than other conventional methods, and labia majora fat filling augmentation application can be performed with more permanent and longer-lasting outcomes than fat transfer only. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.


Assuntos
Tecido Adiposo , Rejuvenescimento , Humanos , Feminino , Adulto , Rejuvenescimento/fisiologia , Tecido Adiposo/transplante , Satisfação do Paciente/estatística & dados numéricos , Resultado do Tratamento , Vulva/cirurgia , Seguimentos , Estética , Técnicas Cosméticas
16.
Sex Med Rev ; 12(3): 263-269, 2024 Jun 26.
Artigo em Inglês | MEDLINE | ID: mdl-38751224

RESUMO

INTRODUCTION: Labia minora hypertrophy can be characterized by the labial tissue extending beyond the labia majora; however, the exact definition of hypertrophy is a matter of debate. While the prevalence of labia hypertrophy is very common among women, taboo/controversial attitudes and surgical interventions still dominate. The recognition and study of labia minora hypertrophy will increase our knowledge of this underrepresented anatomic diversity. OBJECTIVES: To provide a report of the current literature on labia hypertrophy and discuss the definition, etiology, attitudes, management, and medicalization surrounding labia minora hypertrophy and the implications. METHODS: Comprehensive review of literature pertaining to labia minora hypertrophy. RESULTS: Labia minora appearance and measurements vary extensively, and hypertrophy is extremely prevalent in the population and largely nonpathologic. There remains a lack of standardized criteria to define labia hypertrophy. Attitudes surrounding labia hypertrophy differ globally, but in Western nations the overwhelming sentiment toward labia hypertrophy has largely been medicalized. CONCLUSION: Negative attitudes and unnecessary medicalization of nonpathologic instances of labia hypertrophy is unjustifiable and comes with potential risks. There remains an impending need to demedicalize nonpathologic elongated labia, educate the public on diverse genital appearance, and improve understanding of the long-term outcomes and risks of genital cosmetic surgery.


Assuntos
Hipertrofia , Vulva , Humanos , Feminino , Vulva/patologia , Vulva/cirurgia , Vulva/anatomia & histologia
17.
J Cutan Pathol ; 51(8): 583-588, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38695362

RESUMO

Mammary-type tissue in the vulva was first described in 1872 but has been rarely reported in the literature. This tissue was previously considered as ectopic breast tissue that occurs as a result of incomplete regression of the milk line. Similar to native breast tissue, ectopic mammary tissue is hormone-sensitive and can develop benign changes, such as fibroadenoma, as well as malignant changes. A more recent theory suggests that these benign and malignant mammary-type entities arise from mammary-like anogenital glands, which constitute normal vulvar components. We report a case of a 41-year-old woman who presented with a chronic asymptomatic cyst on the left vulva that eventually became uncomfortable, especially on standing. The cyst was located on the labium minus, measuring 1.0 × 0.5 cm, with no identified erythema or other skin abnormalities. Excision of the lesion and subsequent microscopic examination showed a circumscribed mass with a nodular overgrowth of epithelial and stromal components, resembling a mammary fibroadenoma with pseudoangiomatous stromal hyperplasia. We bring to attention this rare diagnosis and the importance of considering it in the presence of a vulvar lesion. The malignant and recurrence potential of mammary-type tissue necessitates excision with clear margins and close monitoring of these patients.


Assuntos
Angiomatose , Fibroadenoma , Hiperplasia , Neoplasias Vulvares , Humanos , Feminino , Adulto , Fibroadenoma/patologia , Fibroadenoma/diagnóstico , Hiperplasia/patologia , Angiomatose/patologia , Angiomatose/diagnóstico , Angiomatose/metabolismo , Neoplasias Vulvares/patologia , Neoplasias Vulvares/metabolismo , Neoplasias Vulvares/diagnóstico , Vulva/patologia , Doenças Mamárias
18.
Maturitas ; 186: 108006, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38704313

RESUMO

Genitourinary syndrome of menopause is a comprehensive term that groups genital, urinary and sexual signs and symptoms mainly due sex hormone deficiency and aging, with a crucial impact on quality of life of midlife women. While this broad definition captures the common underlying physiopathology and the frequent overlap of symptomatology, improving knowledge about different components of genitourinary syndrome of menopause may be relevant for individualized treatment, with possible implications for efficacy, compliance and satisfaction. This narrative review focuses on the vulvar component of genitourinary syndrome of menopause, highlighting anatomical and functional peculiarities of the vulva that are responsible for some of the self-reported symptoms, as well as specific signs at physical examination. Increasing evidence points towards a pivotal role of vulvar vestibular health in the occurrence of sexual pain, one of the most common and distressing symptoms of genitourinary syndrome of menopause, which should be evaluated with validated scales taking a biopsychosocial perspective. This is an essential step in the recognition of different phenotypes of genitourinary syndrome of menopause and in the assessment of the most effective diagnostic and therapeutic algorithm. Menopausal vulvar health deserves more research into tailored non-hormonal and hormonal treatment options.


Assuntos
Menopausa , Vulva , Humanos , Feminino , Menopausa/fisiologia , Vulva/fisiopatologia , Síndrome , Doenças Urogenitais Femininas/fisiopatologia , Doenças Urogenitais Femininas/terapia , Doenças Urogenitais Femininas/etiologia , Disfunções Sexuais Fisiológicas/etiologia , Disfunções Sexuais Fisiológicas/terapia , Disfunções Sexuais Fisiológicas/fisiopatologia , Qualidade de Vida , Doenças da Vulva/diagnóstico , Doenças da Vulva/fisiopatologia , Doenças da Vulva/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA